Di Peng

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

A CREM-ITGA2B-MAPK axis drives proliferation and invasiveness in gastric cancer: insights from single-cell analysis.

A CREM-ITGA2B-MAPK axis drives proliferation and invasiveness in gastric cancer: insights from single-cell analysis.

Journal: Cellular oncology (Dordrecht, Netherlands)
Published: August 19, 2025

Recurrence Prediction by Multi-Omics in the Patient with Colorectal Peritoneal Metastases After Cytoreductive Surgery: A Prospective Biomarker Study.

Recurrence Prediction by Multi-Omics in the Patient with Colorectal Peritoneal Metastases After Cytoreductive Surgery: A Prospective Biomarker Study.

Journal: Cancer management and research
Published: January 31, 2025

LTF as a Potential Predictive Biomarker for Durable Benefit From First-Line Chemo-Immunotherapy in Small Cell Lung Cancer.

LTF as a Potential Predictive Biomarker for Durable Benefit From First-Line Chemo-Immunotherapy in Small Cell Lung Cancer.

Journal: Cancer science
Published: December 27, 2024

Identification of IGF2BPs-related mRNA signature for predicting the overall survival of lung adenocarcinoma.

Identification of IGF2BPs-related mRNA signature for predicting the overall survival of lung adenocarcinoma.

Journal: Scientific reports
Published: August 26, 2024

Evaluation of Molecular Residual Disease by a Fixed Panel in Resectable Colorectal Cancer.

Evaluation of Molecular Residual Disease by a Fixed Panel in Resectable Colorectal Cancer.

Journal: Cancer research and treatment
Published: December 28, 2023

Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104).

Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104).

Journal: Cell reports. Medicine
Published: November 02, 2023

Individualized tumor-informed circulating tumor DNA analysis for postoperative monitoring of non-small cell lung cancer.

Individualized tumor-informed circulating tumor DNA analysis for postoperative monitoring of non-small cell lung cancer.

Journal: Cancer cell
Published: February 02, 2023

CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade.

CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade.

Journal: Cancer discovery
Published: September 13, 2017

Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression.

Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression.

Journal: Nature communications
Published: July 13, 2014
Showing 1-9 of 9

Last Updated: 09/26/2026